Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: UPF 1069
  • Price: $400.0/100mg $800.0/250mg $1800.0/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

1048371-03-4

1048371-03-4 structure
1048371-03-4 structure
  • Name: UPF 1069
  • Chemical Name: 5-phenacyloxy-2H-isoquinolin-1-one
  • CAS Number: 1048371-03-4
  • Molecular Formula: C17H13NO3
  • Molecular Weight: 279.290
  • Catalog: Biochemical Inhibitor DNA damage PARP inhibitor
  • Create Date: 2018-12-17 08:49:51
  • Modify Date: 2024-01-02 21:10:38
  • UPF 1069 is a PARP inhibitor, with IC50s of 8 and 0.3 μM for PARP-1 and PARP-2, respectively.

Name 5-phenacyloxy-2H-isoquinolin-1-one
Synonyms 5-(2-Oxo-2-phenylethoxy)isoquinolin-1(2H)-one
1(2H)-Isoquinolinone, 5-(2-oxo-2-phenylethoxy)-
UPF 1069
5-(2-Oxo-2-phenylethoxy)-1(2H)-isoquinolinone
Description UPF 1069 is a PARP inhibitor, with IC50s of 8 and 0.3 μM for PARP-1 and PARP-2, respectively.
Related Catalog
Target

PARP-2:0.3 μM (IC50)

PARP-1:8 μM (IC50)

In Vitro UPF 1069 (Compound 55) is a PARP inhibitor, with IC50s of 8 and 0.3 μM for PARP-1 and PARP-2, respectively[1]. UPF 1069 (1 µM) reduces the residual PARP activity by approximately 80% of PARP-1-deficient fibroblasts, but only slightly inhibits the enzymic activity in wild-type fibroblasts. UPF 1069 (0.1-1 µM) markedly enhances CA1 hippocampal damage. UPF 1069 (10 µM) also exacerbates oxygen-glucose deprivation (OGD) damage in organotypic hippocampal slices. However, UPF 1069 alleviates the damage cuased by OGD in mixed cortical cell cultures, shows a potent neuroprotective activity both at a concentration (1 µM) selectively acting on PARP-2 and at a concentration (10 µM) inhibiting both PARP-1 and PARP-2 activities[2].
Kinase Assay PARP activity is evaluated by utilizing commercially available recombinant bovine PARP-1 and mouse PARP-2. Briefly, the enzymatic reaction is carried out in 100 µL of 50 mM Tris-HCl (pH 8.0) containing 5 mM MgCl2, 2 mM dithiothreitol, 10 µg sonicated calf thymus DNA, 0.2 µCi [adenine-2,8-3H]NAD and recombinant enzyme PARP-1 or PARP-2 (0.03 U per sample). Different concentrations of the putative inhibitors are added, and the mixture is incubated for 1 h at 37°C. The reaction is terminated by adding 1 mL of 10% trichloroacetic acid (w/v) and centrifuged. Pellets are then washed twice with 1 mL of H2O and resuspended in 1 mL of 0.1 M NaOH. The radioactivity incorporated from [adenine-2,8-3H]NAD into proteins is evaluated by liquid scintillation spectrometry[2].
References

[1]. Pellicciari R, et al. On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives. ChemMedChem. 2008 Jun;3(6):914-23.

[2]. Moroni F, et al. Selective PARP-2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post-ischaemic brain damage.

Density 1.3±0.1 g/cm3
Boiling Point 570.3±50.0 °C at 760 mmHg
Melting Point 166-168 °C
Molecular Formula C17H13NO3
Molecular Weight 279.290
Flash Point 298.7±30.1 °C
Exact Mass 279.089539
PSA 59.42000
LogP 2.22
Vapour Pressure 0.0±1.6 mmHg at 25°C
Index of Refraction 1.618
Storage condition Store at RT
Hazard Codes Xn
Risk Phrases 22